Form 4: Dolby CEO Yeaman Exercises Options, Sells Shares

Dolby Laboratories President and CEO Kevin J. Yeaman exercised stock options and simultaneously sold an equivalent number of shares on October 14, 2025, as part of a Rule 10b5-1 plan.

Summary

• Kevin J. Yeaman, President and CEO, and a Director of Dolby Laboratories, Inc. (DLB), executed transactions on October 14, 2025, under a Rule 10b5-1 plan.
• Exercised employee stock options to acquire 25,000 shares of Class A Common Stock at an exercise price of $45.50 per share.
• Sold 11,214 shares of Class A Common Stock at a weighted average price of $68.5057 per share.
• Sold an additional 13,786 shares of Class A Common Stock at a weighted average price of $69.173 per share.
• The total number of shares sold (25,000) precisely matched the number of shares acquired through the option exercise.
• Following these transactions, Mr. Yeaman's indirect beneficial ownership through a trust is 114,725 shares of Class A Common Stock, and direct ownership includes 127,735 shares underlying restricted stock units.

Sentiment

Score: 6

Explanation: The transactions represent a routine insider stock option exercise and sale under a pre-arranged 10b5-1 plan, which is generally neutral. The significant difference between the exercise price and sale price indicates a profitable event for the insider, which can be seen as a minor positive.

Positives

• The option exercise price of $45.50 is significantly lower than the sale prices ($68.5057 and $69.173), indicating a substantial realized gain for the reporting person.
• The transactions were conducted under a Rule 10b5-1 plan, demonstrating pre-planned and transparent insider trading activity.

Negatives

• The sale of shares by a high-ranking insider, even when offset by option exercise, reduces the insider's direct exposure to the company's stock, which some investors might view cautiously.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Industry Context

This Form 4 filing details an insider transaction specific to Dolby Laboratories, Inc. and does not provide information directly related to broader industry trends or competitive landscape.

Corporate Governance

Related Party Transactions

• The transactions involved shares held indirectly by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.
• Shares are also beneficially owned indirectly by a son of the reporting person.

Stakeholder Impact

• Shareholders may note the insider's activity, particularly the profitable exercise of options, which is a common form of executive compensation.
• The use of a Rule 10b5-1 plan provides transparency to all stakeholders regarding the insider's trading intentions.

Key Dates

Recommendation

The filing details a routine insider transaction (option exercise and sale) executed under a pre-arranged Rule 10b5-1 plan. Such transactions are generally not indicative of a change in the company's fundamental outlook or a strong signal for future stock performance. While the insider realized a profit, the net effect on their direct/indirect share count from these specific transactions is neutral. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to alter an existing investment thesis.

Keywords

Dolby Laboratories, DLB, Insider Transaction, Form 4, Stock Options, Share Sale, Executive Compensation, Rule 10b5-1